Patents by Inventor Ivis Munoz

Ivis Munoz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220080084
    Abstract: The present disclosure relates to methods for producing tissue matrix products with active agents to achieve localized distribution and controlled active agent release. The method can include inserting a carrier element comprising a biodegradable material and active agent into surface features of a tissue matrix product. Also provided are tissue matrix products made using the disclosed methods.
    Type: Application
    Filed: November 22, 2021
    Publication date: March 17, 2022
    Inventors: Israel James Jessop, Ming F. Pomerleau, Mrinal Shah, Ivis Munoz, Talia Connell
  • Publication number: 20200323617
    Abstract: The present disclosure provides tissue fillers. The tissue fillers can include a plurality of tissue particles formed from acellular tissue matrix fragments. The tissue fillers can be used to fill tissue sites, such as voids formed after tissue resection.
    Type: Application
    Filed: June 30, 2020
    Publication date: October 15, 2020
    Inventors: Mark Hayzlett, Ivis Munoz, Nimesh Kabaria, Joshua Czeczuga
  • Patent number: 10722339
    Abstract: The present disclosure provides tissue fillers. The tissue fillers can include a plurality of tissue particles formed from acellular tissue matrix fragments. The tissue fillers can be used to fill tissue sites, such as voids formed after tissue resection.
    Type: Grant
    Filed: January 30, 2018
    Date of Patent: July 28, 2020
    Assignee: LifeCell Corporation
    Inventors: Mark Hayzlett, Ivis Munoz, Nimesh Kabaria, Joshua Czeczuga
  • Publication number: 20190224376
    Abstract: The present disclosure relates to methods for producing tissue matrix products with active agents to achieve localized distribution and controlled active agent release. The method can include inserting a carrier element comprising a biodegradable material and active agent into surface features of a tissue matrix product. Also provided are tissue matrix products made using the disclosed methods.
    Type: Application
    Filed: January 22, 2019
    Publication date: July 25, 2019
    Inventors: Israel James Jessop, Ming F. Pomerleau, Mrinal Shah, Ivis Munoz, Talia Connell
  • Publication number: 20180153675
    Abstract: The present disclosure provides tissue fillers. The tissue fillers can include a plurality of tissue particles formed from acellular tissue matrix fragments. The tissue fillers can be used to fill tissue sites, such as voids formed after tissue resection.
    Type: Application
    Filed: January 30, 2018
    Publication date: June 7, 2018
    Applicant: LifeCell Corporation
    Inventors: Mark Hayzlett, Ivis Munoz, Nimesh Kabaria, Joshua Czeczuga
  • Patent number: 9913705
    Abstract: The present disclosure provides tissue fillers. The tissue fillers can include a plurality of tissue particles formed from acellular tissue matrix fragments. The tissue fillers can be used to fill tissue sites, such as voids formed after tissue resection.
    Type: Grant
    Filed: December 13, 2016
    Date of Patent: March 13, 2018
    Assignee: LifeCell Corporation
    Inventors: Mark Hayzlett, Ivis Munoz, Nimesh Kabaria, Joshua Czeczuga
  • Publication number: 20170086962
    Abstract: The present disclosure provides tissue fillers. The tissue fillers can include a plurality of tissue particles formed from acellular tissue matrix fragments. The tissue fillers can be used to fill tissue sites, such as voids formed after tissue resection.
    Type: Application
    Filed: December 13, 2016
    Publication date: March 30, 2017
    Applicant: LifeCell Corporation
    Inventors: Mark Hayzlett, Ivis Munoz, Nimesh Kabaria, Joshua Czeczuga
  • Patent number: 9549805
    Abstract: The present disclosure provides tissue fillers. The tissue fillers can include a plurality of tissue particles formed from acellular tissue matrix fragments. The tissue fillers can be used to fill tissue sites, such as voids formed after tissue resection. The disclosure also includes methods of treating tissue using the tissue fillers. The tissue particles can each be formed of tissue fragments having certain sizes.
    Type: Grant
    Filed: December 18, 2012
    Date of Patent: January 24, 2017
    Assignee: LifeCell Corporation
    Inventors: Mark Hayzlett, Ivis Munoz, Nimesh Kabaria, Joshua Czeczuga
  • Publication number: 20130158676
    Abstract: The present disclosure provides tissue fillers. The tissue fillers can include a plurality of tissue particles formed from acellular tissue matrix fragments. The tissue fillers can be used to fill tissue sites, such as voids formed after tissue resection.
    Type: Application
    Filed: December 18, 2012
    Publication date: June 20, 2013
    Inventors: Mark Hayzlett, Ivis Munoz, Nimesh Kabaria, Joshua Czeczuga